Cargando…
Assessing Specificity of Anticancer Drugs In Vitro
A procedure for assessing specificity of anticancer drugs in vitro using cultures containing both tumor and non-tumor cells is demonstrated. The key element is the quantitative determination of a tumor-specific genetic alteration in relation to a universal sequence using a dual-probe digital PCR ass...
Autor principal: | Kluwe, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841310/ https://www.ncbi.nlm.nih.gov/pubmed/27078035 http://dx.doi.org/10.3791/53752 |
Ejemplares similares
-
Preclinical Assessment of the Anticancer Drug Response of Plexiform Neurofibroma Tissue Using Primary Cultures
por: Jiang, Wei, et al.
Publicado: (2015) -
Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020) -
Differences in ICU Outcomes According to the Type of Anticancer Drug in Lung Cancer Patients
por: Hong, Yoonki, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022) -
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
por: Papazoglou, Panagiota, et al.
Publicado: (2021)